CD34 and acute lymphoblastic leukemia: Interestingly, despite the fact that the CD34 marker seems to be useful to enrich LSC activity from T-ALL samples, immunophenotyping of donor-derived blasts in xenograft samples revealed that CD34+ blasts may lose the CD34 maker after transplantation, and vice versa [57].